{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:25:32Z","timestamp":1778631932164,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T00:00:00Z","timestamp":1436140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T00:00:00Z","timestamp":1436140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1038\/bmt.2015.161","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T15:27:39Z","timestamp":1436196459000},"page":"1321-1325","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy"],"prefix":"10.1038","volume":"50","author":[{"given":"K","family":"Balassa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Andrikovics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Remenyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Batai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Bors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K P","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Szilvasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Rajczy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Inotai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Gopcsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Barta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Reti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Tordai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Masszi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,6]]},"reference":[{"key":"BFbmt2015161_CR1","first-page":"152","volume":"2","author":"CC Uderzo","year":"2014","unstructured":"Uderzo CC, Jodele S, Missiry ME, Ciceri F, Busca AB, Bacigalupo A et al. Transplant-associated thrombotic microangiopathy (TA-TMA) and consensus based diagnostic and therapeutic recommendations: which TA-TMA patients to treat and when? J Bone Marrow Res 2014; 2: 152.","journal-title":"J Bone Marrow Res"},{"key":"BFbmt2015161_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","volume":"40","author":"ED Batts","year":"2007","unstructured":"Batts ED, Lazarus HM . Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? Bone Marrow Transplant 2007; 40: 709\u2013719.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015161_CR3","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","volume":"118","author":"BL Laskin","year":"2011","unstructured":"Laskin BL, Goebel J, Davies SM, Jodele S . Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood 2011; 118: 1452\u20131462.","journal-title":"Blood"},{"key":"BFbmt2015161_CR4","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1537-2995.2004.00700.x","volume":"44","author":"JN George","year":"2004","unstructured":"George JN, Li X, McMinn JR, Terrell DR, Vesely SK, Selby GB . Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion 2004; 44: 294\u2013304.","journal-title":"Transfusion"},{"key":"BFbmt2015161_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/CCO.0b013e3280148a2f","volume":"19","author":"K Kojouri","year":"2007","unstructured":"Kojouri K, George JN . Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation. Curr Opin Oncol 2007; 19: 148\u2013154.","journal-title":"Curr Opin Oncol"},{"key":"BFbmt2015161_CR6","doi-asserted-by":"publisher","first-page":"e2010033","DOI":"10.4084\/mjhid.2010.033","volume":"2","author":"E Stavrou","year":"2010","unstructured":"Stavrou E, Lazarus HM . Thrombotic microangiopathy in haematopoietic cell transplantation: an update. Mediterr J Hematol Infect Dis 2010; 2: e2010033.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"BFbmt2015161_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.bbmt.2006.11.020","volume":"13","author":"B Oran","year":"2007","unstructured":"Oran B, Donato M, Aleman A, Hosing C, Korbling M, Detry MA et al. Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment. Biol Blood Marrow Transplant 2007; 13: 469\u2013477.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015161_CR8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1046\/j.1365-2141.2002.03721.x","volume":"118","author":"T Ruutu","year":"2002","unstructured":"Ruutu T, Hermans J, Niederwieser D, Gratwohl A, Kiehl M, Volin L et al. Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 2002; 118: 1112\u20131119.","journal-title":"Br J Haematol"},{"key":"BFbmt2015161_CR9","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","volume":"90","author":"BS Cho","year":"2010","unstructured":"Cho BS, Yahng SA, Lee SE, Eom KS, Kim YJ, Kim HJ et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation 2010; 90: 918\u2013926.","journal-title":"Transplantation"},{"key":"BFbmt2015161_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/bmt.2009.230","volume":"45","author":"E Willems","year":"2010","unstructured":"Willems E, Baron F, Seidel L, Fr\u00e8re P, Fillet G, Beguin Y . Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning. Bone Marrow Transplant 2010; 45: 689\u2013693.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015161_CR11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/bmt.2014.17","volume":"49","author":"J Labrador","year":"2014","unstructured":"Labrador J, L\u00f3pez-Corral L, L\u00f3pez-Godino O, V\u00e1zquez L, Cabrero-Calvo M, P\u00e9rez-L\u00f3pez R et al. Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus. Bone Marrow Transplant 2014; 49: 684\u2013690.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015161_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.bbmt.2012.10.006","volume":"19","author":"S Shayani","year":"2013","unstructured":"Shayani S, Palmer J, Stiller T, Liu X, Thomas SH, Khuu T et al. Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus\/sirolimus-based graft-versus-host disease prophylaxis. Biol Blood Marrow Transplant 2013; 19: 298\u2013304.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015161_CR13","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1182\/blood-2009-03-207563","volume":"115","author":"R Rodriguez","year":"2010","unstructured":"Rodriguez R, Nakamura R, Palmer JM, Parker P, Shayani S, Nademanee A et al. A phase II pilot study of tacrolimus\/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens. Blood 2010; 115: 1098\u20131105.","journal-title":"Blood"},{"key":"BFbmt2015161_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/pbc.22861","volume":"57","author":"J Rosenthal","year":"2011","unstructured":"Rosenthal J, Pawlowska A, Bolotin E, Cervantes C, Maroongroge S, Thomas SH et al. Transplant-associated thrombotic microangiopathy in pediatric patients treated with sirolimus and tacrolimus. Pediatr Blood Cancer 2011; 57: 142\u2013146.","journal-title":"Pediatr Blood Cancer"},{"key":"BFbmt2015161_CR15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/bmt.2012.175","volume":"48","author":"SK Khaled","year":"2013","unstructured":"Khaled SK, Palmer J, Stiller T, Senitzer D, Maegawa R, Rodriguez R et al. A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant. Bone Marrow Transplant 2013; 48: 278\u2013283.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015161_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbmt.2008.11.004","volume":"15","author":"U Platzbecker","year":"2009","unstructured":"Platzbecker U, von Bonin M, Goekkurt E, Radke J, Binder M, Kiani A et al. Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial. Biol Blood Marrow Transplant 2009; 15: 101\u2013108.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015161_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2215\/CJN.02070508","volume":"4","author":"S Changsirikulchai","year":"2009","unstructured":"Changsirikulchai S, Myerson D, Guthrie KA, McDonald GB, Alpers CE, Hingorani SR . Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol 2009; 4: 345\u2013353.","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFbmt2015161_CR18","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/sj.bmt.1705976","volume":"41","author":"BS Cho","year":"2008","unstructured":"Cho BS, Min CK, Eom KS, Kim YJ, Kim HJ, Lee S et al. Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 41: 813\u2013820.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015161_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.transci.2007.03.004","volume":"36","author":"N Worel","year":"2007","unstructured":"Worel N, Greinix HT, Leitner G, Mitterbauer M, Rabitsch W, Rosenmayr A et al. ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy. Transfus Apher Sci 2007; 36: 297\u2013304.","journal-title":"Transfus Apher Sci"},{"key":"BFbmt2015161_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-med-061813-013241","volume":"66","author":"XL Zheng","year":"2015","unstructured":"Zheng XL . ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. Annu Rev Med 2015; 66: 211\u2013225.","journal-title":"Annu Rev Med"},{"key":"BFbmt2015161_CR21","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/bmt.2009.233","volume":"45","author":"GA Kennedy","year":"2010","unstructured":"Kennedy GA, Kearey N, Bleakley S, Butler J, Mudie K, Durrant S . Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange. Bone Marrow Transplant 2010; 45: 699\u2013704.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015161_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1538-7836.2009.03692.x","volume":"8","author":"M Scully","year":"2010","unstructured":"Scully M, Brown J, Patel R, McDonald V, Brown CJ, Machin S . Human leukocyte antigen association in idiopathic thrombotic thrombocytopenic purpura: evidence for an immunogenetic link. J Thromb Haemost 2010; 8: 257\u2013262.","journal-title":"J Thromb Haemost"},{"key":"BFbmt2015161_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00277-011-1384-z","volume":"91","author":"ML John","year":"2012","unstructured":"John ML, Hitzler W, Scharrer I . The role of human leukocyte antigens as predisposing and\/or protective factors in patients with idiopathic thrombotic thrombocytopenic purpura. Ann Hematol 2012; 91: 507\u2013510.","journal-title":"Ann Hematol"},{"key":"BFbmt2015161_CR24","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/j.1538-7836.2010.03772.x","volume":"8","author":"P Coppo","year":"2010","unstructured":"Coppo P, Busson M, Veyradier A, Wynckel A, Poullin P, Azoulay E et al. HLA-DRB1*11: a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians. J Thromb Haemost 2010; 8: 856\u2013859.","journal-title":"J Thromb Haemost"},{"key":"BFbmt2015161_CR25","first-page":"825","volume":"15","author":"D Przepiorka","year":"1994","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015161_CR26","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","volume":"11","author":"VT Ho","year":"2005","unstructured":"Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M et al. Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 571\u2013575.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015161_CR27","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ . A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496\u2013509.","journal-title":"J Am Stat Assoc"},{"key":"BFbmt2015161_CR28","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1182\/blood-2010-01-265728","volume":"115","author":"MA Kharfan-Dabaja","year":"2010","unstructured":"Kharfan-Dabaja MA, Pidala J, Anasetti C . Thrombotic microangiopathy after GVHD prophylaxis with tacrolimus\/sirolimus: a call for use of consensus definition in reporting. Blood 2010; 115: 4316\u20134317.","journal-title":"Blood"},{"key":"BFbmt2015161_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3324\/haematol.10699","volume":"92","author":"T Ruutu","year":"2007","unstructured":"Ruutu T, Barosi G, Benjamin RJ, Clark RE, George JN, Gratwohl A et al. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica 2007; 92: 95\u2013100.","journal-title":"Haematologica"},{"key":"BFbmt2015161_CR30","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1111\/j.1537-2995.2009.02217.x","volume":"49","author":"GA Kennedy","year":"2009","unstructured":"Kennedy GA, Bleakley S, Butler J, Mudie K, Kearey N, Durrant S . Posttransplant thrombotic microangiopathy: sensitivity of proposed new diagnostic criteria. Transfusion 2009; 49: 1884\u20131889.","journal-title":"Transfusion"},{"key":"BFbmt2015161_CR31","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","volume":"124","author":"S Jodele","year":"2014","unstructured":"Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J et al. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults. Blood 2014; 124: 645\u2013653.","journal-title":"Blood"},{"key":"BFbmt2015161_CR32","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/bmt.2011.243","volume":"47","author":"S Goyama","year":"2012","unstructured":"Goyama S, Takeuchi K, Kanda Y, Nannya Y, Chiba S, Fukayama M et al. Post-transplant endothelial disorder after hematopoietic SCT: a blinded autopsy study. Bone Marrow Transplant 2012; 47: 1243\u20131245.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015161_CR33","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/bjh.12956","volume":"166","author":"E Arons","year":"2014","unstructured":"Arons E, Adams S, Venzon DJ, Pastan I, Kreitman RJ . Class II human leucocyte antigen DRB1*11 in hairy cell leukaemia patients with and without haemolytic uraemic syndrome. Br J Haematol 2014; 166: 729\u2013738.","journal-title":"Br J Haematol"},{"key":"BFbmt2015161_CR34","first-page":"1481","volume":"32","author":"DD Gladman","year":"2005","unstructured":"Gladman DD, Kung TN, Siannis F, Pellett F . Farewell VT, Lee P. HLA markers for susceptibility and expression in scleroderma. J Rheumatol 2005; 32: 1481\u20131487.","journal-title":"J Rheumatol"},{"key":"BFbmt2015161_CR35","first-page":"10","volume":"72","author":"JD Reveille","year":"2005","unstructured":"Reveille JD . Genetic studies in the rheumatic diseases: present status and implications for the future. J Rheumatol Suppl 2005; 72: 10\u201313.","journal-title":"J Rheumatol Suppl"},{"key":"BFbmt2015161_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2340\/00015555-1884","volume":"95","author":"L Pavlovsky","year":"2015","unstructured":"Pavlovsky L, Israeli M, Sagy E, Berg AL, David M, Shemer A et al. Lichen planopilaris is associated with HLA DRB1*11 and DQB1*03 alleles. Acta Derm Venereol 2015; 95: 177\u2013180.","journal-title":"Acta Derm Venereol"},{"key":"BFbmt2015161_CR37","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00296-012-2661-4","volume":"33","author":"X He","year":"2013","unstructured":"He X, Yu C, Zhao P, Ding Y, Liang X, Zhao Y et al. The genetics of Henoch-Sch\u00f6nlein purpura: a systematic review and meta-analysis. Rheumatol Int 2013; 33: 1387\u20131395.","journal-title":"Rheumatol Int"},{"key":"BFbmt2015161_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/09537100400028685","volume":"16","author":"D Veneri","year":"2005","unstructured":"Veneri D, De Matteis G, Solero P, Federici F, Zanuso C, Guizzardi E et al. Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: correlation with Helicobacter pylori infection and response to eradication treatment. Platelets 2005; 16: 307\u2013311.","journal-title":"Platelets"},{"key":"BFbmt2015161_CR39","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1046\/j.1365-2141.2002.03926.x","volume":"119","author":"I Theodorou","year":"2002","unstructured":"Theodorou I, Abel L, Mauro F, Duprey B, Magnac C, Payelle-Brogard B et al. High occurence of DRB1 11 in chronic lymphocytic leukaemia families. Br J Haematol 2002; 119: 713\u2013715.","journal-title":"Br J Haematol"},{"key":"BFbmt2015161_CR40","first-page":"400","volume":"63","author":"EJ Davidson","year":"2003","unstructured":"Davidson EJ, Davidson JA, Sterling JC, Baldwin PJ, Kitchener HC, Stern PL . Association between human leukocyte antigen polymorphism and human papillomavirus 16-positive vulval intraepithelial neoplasia in British women. Cancer Res 2003; 63: 400\u2013403.","journal-title":"Cancer Res"},{"key":"BFbmt2015161_CR41","first-page":"97","volume":"26","author":"C Climent","year":"2007","unstructured":"Climent C, Nazario CM, Umpierre S, Quintero M, Gorbea S . Major histocompatibility complex class II polymorphisms and risk of cervical cancer in Puerto Rican women. P R Health Sci J 2007; 26: 97\u2013101.","journal-title":"P R Health Sci J"},{"key":"BFbmt2015161_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0039.1983.tb00364.x","volume":"21","author":"MS Pollack","year":"1983","unstructured":"Pollack MS, Safai B, Myskowski PL, Gold JW, Pandey J, Dupont B . Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma. Tissue Antigens 1983; 21: 1\u20138.","journal-title":"Tissue Antigens"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2015161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2015161","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2015161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T18:16:44Z","timestamp":1648059404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2015161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,6]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["BFbmt2015161"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2015.161","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,6]]},"assertion":[{"value":"27 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}